AYTU BioPharma
AYTU
AYTU
37 hedge funds and large institutions have $5.39M invested in AYTU BioPharma in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 15 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
40% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 15
56% less capital invested
Capital invested by funds: $12.2M → $5.39M (-$6.83M)
Holders
37
Holding in Top 10
–
Calls
$245K
Puts
$24K
Top Buyers
| 1 | +$297K | |
| 2 | +$70K | |
| 3 | +$67.2K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$36.9K |
| 5 |
Two Sigma Advisers
New York
|
+$24K |
Top Sellers
| 1 | -$254K | |
| 2 | -$167K | |
| 3 | -$165K | |
| 4 |
D.E. Shaw & Co
New York
|
-$113K |
| 5 |
Millennium Management
New York
|
-$87K |